Si-bone, Inc. cash flow statement
In fiscal 2025, Si-bone, Inc.'s operations generated −$675,000 of cash; it spent $8.4m on capital projects, leaving free cash flow of −$9.1m.
Cash flow statement
| Fiscal year | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −18 | −15 | −32 | −31 | −40 | −42 | −19 | −12 | −1 | 2 |
| Depreciation and amortisation | 1 | 1 | 1 | 1 | 2 | 3 | 5 | 4 | 6 | 6 |
| Stock-based pay | 1 | 2 | 7 | 12 | 17 | 23 | 24 | 26 | 26 | 24 |
| Capital spending | 0 | 1 | 2 | 3 | 6 | 10 | 8 | 10 | 8 | 7 |
| Free cash flow | −18 | −15 | −34 | −33 | −46 | −51 | −27 | −23 | −9 | −4 |
| Free cash flow after stock pay | −19 | −18 | −42 | −45 | −63 | −74 | −51 | −49 | −35 | −29 |
| Share buybacks | 0 | 0 | 0 | — | — | — | — | — | — | — |
| Shares issued | — | — | 0 | 135 | 0 | 0 | 84 | 0 | 0 | — |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 0 | 1 | −5 | 0 | 2 | 2 | −2 | 1 |
| Depreciation and amortisation | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Stock-based pay | 6 | 6 | 7 | 7 | 6 | 6 | 6 | 6 |
| Capital spending | 3 | 2 | 2 | 2 | 3 | 1 | 1 | 2 |
| Free cash flow | −3 | −1 | −7 | −2 | −1 | 0 | −3 | −1 |
| Free cash flow after stock pay | −9 | −7 | −14 | −9 | −7 | −6 | −9 | −7 |
| Shares issued | 0 | 0 | — | — | — | — | — | — |
Compare with peers
- Treace Medical Concepts, Inc. cash flow
- Lakeland Industries Inc cash flow
- Establishment Labs Holdings Inc. cash flow
- Cerus Corp cash flow
- Lemaitre Vascular Inc cash flow
Head to head: SIBN vs TMCILAKE vs SIBNESTA vs SIBN
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies